Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | SLC6A14 |
| Upstream (Parents) |
|---|
| (<<) CRYAB → SLC6A14 |
| (<<) EGFR → SLC6A14 |
| (<<) EPHB3 → SLC6A14 |
| (<<) FZD7 → SLC6A14 |
| (<<) HSPB1 → SLC6A14 |
| (<<) ITGA6 → SLC6A14 |
| (<<) KLK5 → SLC6A14 |
| (<<) KLK8 → SLC6A14 |
| (<<) KRT5 → SLC6A14 |
| (<<) KRT6B → SLC6A14 |
| (<<) PHGDH → SLC6A14 |
| (<<) PLA2G4A → SLC6A14 |
| (<<) PRNP → SLC6A14 |
| (<<) RHOB → SLC6A14 |
| (<<) RND3 → SLC6A14 |
| (<<) SERPINB5 → SLC6A14 |
| (<<) TCF7L1 → SLC6A14 |
| (<<) UBE2E3 → SLC6A14 |
| (<<) VAV3 → SLC6A14 |
| Downstream (Children) |
|---|
| SLC6A14 → ALOX15B (>>) |
| SLC6A14 → ALPPL2 (>>) |
| SLC6A14 → ANGPTL4 (>>) |
| SLC6A14 → ARSJ (>>) |
| SLC6A14 → ASTN2 (>>) |
| SLC6A14 → ATF4 (>>) |
| SLC6A14 → B3GNT3 (>>) |
| SLC6A14 → BCL2 (>>) |
| SLC6A14 → BMP2 (>>) |
| SLC6A14 → CHODL (>>) |
| SLC6A14 → CRCT1 (>>) |
| SLC6A14 → CXADR (>>) |
| SLC6A14 → CXCL2 (>>) |
| SLC6A14 → EGF (>>) |
| SLC6A14 → ELF5 (>>) |
| SLC6A14 → EML4 (>>) |
| SLC6A14 → EPHA2 (>>) |
| SLC6A14 → ETS2 (>>) |
| SLC6A14 → FGFR3 (>>) |
| SLC6A14 → FZD5 (>>) |
| SLC6A14 → HDAC11 (>>) |
| SLC6A14 → IL6 (>>) |
| SLC6A14 → KCNN4 (>>) |
| SLC6A14 → KLK10 (>>) |
| SLC6A14 → LBX1 (>>) |
| SLC6A14 → LRP6 (>>) |
| SLC6A14 → MYL5 (>>) |
| SLC6A14 → PCK2 (>>) |
| SLC6A14 → PLCB4 (>>) |
| SLC6A14 → PLCD1 (>>) |
| SLC6A14 → PODXL (>>) |
| SLC6A14 → PRKCD (>>) |
| SLC6A14 → PTGS2 (>>) |
| SLC6A14 → PYGB (>>) |
| SLC6A14 → RARB (>>) |
| SLC6A14 → RASSF1 (>>) |
| SLC6A14 → RHOT2 (>>) |
| SLC6A14 → SLPI (>>) |
| SLC6A14 → SMOX (>>) |
| SLC6A14 → SOX9 (>>) |
| SLC6A14 → ST3GAL6 (>>) |
| SLC6A14 → TGFA (>>) |
| SLC6A14 → TPSG1 (>>) |
| SLC6A14 → TRIB3 (>>) |
| SLC6A14 → TSG101 (>>) |
| SLC6A14 → UST (>>) |
